Latest Period
Q1 2026
Security Snapshot
KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) Institutional Ownership
CUSIP: 483119202
13F Institutional Holders and Ownership History from Q3 2022 to Q1 2026
Institutions Reporting
26
Shares (Excl. Options)
1,699,339
Price
$0.17
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- KALA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,699,339
- Total 13F value
- $293,931
- Portfolio coverage rank
- 0%
- Share change
- -1,140,369
- Value change
- -$1,009,506
- Number of holders
- 26
- Shares outstanding
- 28,929,479
- SEC-reported price per share
- $0.08
- Insider filing price
- $0.08
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 483119202.
- 26 institutions reported positions in Q1 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 28 to 26 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,579,627 to $293,931.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 26 institutions filings for Q1 2026.
Security key
483119202
Latest holder period
Q1 2026
13F holders
26
13D/G owners
7
CIK / CUSIP context first
Open Q1 2026 holders
KALA full holder history
KALA BIO, Inc. SEC filings
KALA BIO, Inc. company facts
KALA BIO, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 483119202:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
KALA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Lazar David E. | 5.2% | $27,522,000 | 49,500,000 | David E. Lazar | 30 Jan 2026 | |||
| LIFESCI CAPITAL, LLC | 7.9% | $1,274,240 | 2,200,000 | LifeSci Capital LLC | 30 Dec 2025 | |||
| OXFORD FINANCE LLC | 16% | $1,215,000 | 1,620,000 | OXFORD FINANCE LLC | 25 Nov 2025 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 4.6% | -15% | $5,255,568 | -$1,020,402 | 344,176 | -16% | SR One Capital Management, LLC | 14 Oct 2025 |
| ADAR1 Capital Management, LLC | 4.9% | $1,270,559 | 298,955 | ADAR1 Capital Management, LLC | 31 Dec 2024 | |||
| BAKER BROS. ADVISORS LP | 0.01% | -100% | $509 | -$635,303 | 2,312 | -100% | Baker Bros. Advisors LP | 31 Mar 2026 |
| Point72 Asset Management, L.P. | 0% | -96% | $393 | -$717,340 | 257 | -100% | Point72 Asset Management, L.P. | 30 Sep 2025 |
As of 31 Mar 2026, 26 institutional investors reported holding 1,699,339 shares of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA). This represents 5.9% of the company’s total 28,929,479 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
15
Latest
Q1 2026
Rows shown
1-15 of 15
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,699,339 | $293,931 | -$1,009,506 | $0.17 | 26 |
| 2025 Q4 | 2,839,708 | $1,579,627 | +$608,308 | $0.56 | 28 |
| 2025 Q3 | 1,734,395 | $2,653,735 | -$8,492,399 | $1.53 | 21 |
| 2025 Q2 | 3,640,815 | $17,329,892 | -$2,659,836 | $4.76 | 28 |
| 2025 Q1 | 4,140,775 | $23,727,155 | +$3,688,829 | $5.73 | 26 |
| 2024 Q4 | 3,460,017 | $24,012,460 | +$9,345,854 | $6.94 | 29 |
| 2024 Q3 | 2,117,088 | $12,067,800 | +$82,464 | $5.70 | 26 |
| 2024 Q2 | 2,091,840 | $14,831,107 | +$10,436,290 | $7.09 | 27 |
| 2024 Q1 | 616,773 | $4,884,504 | +$713,767 | $7.97 | 27 |
| 2023 Q4 | 525,810 | $3,681,120 | +$62,131 | $7.00 | 23 |
| 2023 Q3 | 513,683 | $4,572,074 | +$1,116,796 | $8.90 | 24 |
| 2023 Q2 | 380,984 | $5,558,799 | +$892,555 | $14.59 | 26 |
| 2023 Q1 | 319,440 | $4,808,013 | -$2,074,855 | $15.05 | 22 |
| 2022 Q4 | 324,124 | $12,362,867 | +$12,342,867 | $38.15 | 27 |
| 2022 Q3 | 90,500 | $20,000 | +$20,000 | $0.22 | 1 |